Christiane Hamacher
Market Reacts Negatively To Biocon's Weaker Results, Exit Of Biologics' MD
Banking - Published date: .
Analysts have raised doubts over the $1 billion guidance for biosimilars by FY22 and Hamacher's exit due to "professiona... Read more